In gastric, colorectal and ovarian cancer, PRL-3 expression was associated with tumour stage and extent of lymph node metastasis (Miskad et al, 2004), and for CRC a negative prognostic impact with shorter survival was found (Peng et al, 2004). This evidence concerns the gene PTP4A3 and ovarian cancer.